PRESS RELEASE published on 08/03/2026 at 15:14, 1 month 8 days ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc. The Vanguard Group, Inc. discloses a 13.59% interest in Prologis, Inc. as of 31 July 2026, along with dealings in relevant securities Form 8.3 Securities Dealings Financial Disclosure Interest Disclosure The Vanguard Group, Prologis Inc.
PRESS RELEASE published on 08/03/2026 at 15:14, 1 month 8 days ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited The Vanguard Group, Inc. discloses owning 4.44% of Picton Property Income Limited's securities. Deals made at 0.75 GBP per share. Additional disclosures include consortium involvement Vanguard Group Ownership Disclosure Securities Trading Picton Property Income Limited Consortium Involvement
BRIEF published on 08/03/2026 at 15:12, 1 month 8 days ago The Vanguard Group's Position on Beazley PLC Securities Form 8.3 The Vanguard Group Takeover Code Securities Disclosure Beazley Plc
PRESS RELEASE published on 08/03/2026 at 15:12, 1 month 8 days ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses 5.30% interest in LondonMetric Property plc and 0.92% in Schroder Real Estate Investment Trust Limited as of 31 July 2026 The Vanguard Group, Inc. LondonMetric Property Plc Disclosure Interests Schroder Real Estate Investment Trust Limited
PRESS RELEASE published on 08/03/2026 at 15:11, 1 month 8 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 4.93% interest in JTC plc's 1p ordinary shares as of 31 July 2026 The Vanguard Group, Inc. Disclosure 1p Ordinary Shares JTC Plc 4.93% Interest
PRESS RELEASE published on 08/03/2026 at 15:07, 1 month 8 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley PLC The Vanguard Group, Inc. discloses a 4.99% interest in Beazley PLC's ordinary securities. Position disclosed on 31 July 2026 Securities Disclosure The Vanguard Group Interest Beazley Plc
BRIEF published on 07/31/2026 at 16:27, 1 month 11 days ago The Vanguard Group Discloses Position in Tate & Lyle PLC Disclosure Takeover Code Vanguard Group Shareholdings Tate & Lyle
BRIEF published on 07/31/2026 at 16:26, 1 month 11 days ago Vanguard Discloses Interests in Spire Healthcare Securities Disclosure Takeover Code Spire Healthcare Vanguard
BRIEF published on 07/31/2026 at 16:24, 1 month 11 days ago The Vanguard Group's Disclosure on Segro PLC Form 8.3 Securities Disclosure Vanguard Group SEGRO PLC Investment Dealings
BRIEF published on 07/31/2026 at 16:23, 1 month 11 days ago The Vanguard Group Discloses Position in Schroders PLC Form 8.3 Takeover Code Stock Purchase Schroders Plc Vanguard Group
Published on 09/12/2026 at 02:35, 2 hours 28 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 6 hours 3 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 6 hours 58 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 7 hours 38 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 12 hours 3 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 22:15, 6 hours 48 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 6 hours 53 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 9 hours 18 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 10 hours 48 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 22 hours 3 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 1 day 9 hours ago Availability of the 2026 Interim Financial Report
